Tocqueville Asset Management L.P. Buys New Position in Humana Inc. $HUM

Tocqueville Asset Management L.P. purchased a new stake in Humana Inc. (NYSE:HUM) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 66,567 shares of the insurance provider’s stock, valued at approximately $26,442,000.

Several other institutional investors have also added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in shares of Humana by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock valued at $3,652,890,000 after acquiring an additional 106,030 shares in the last quarter. BlackRock Inc. acquired a new stake in Humana in the 2nd quarter worth approximately $4,138,160,000. Capital International Investors boosted its stake in Humana by 113.9% in the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock worth $1,490,239,000 after purchasing an additional 3,097,571 shares in the last quarter. Pzena Investment Management LLC grew its position in Humana by 34.3% during the 1st quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after purchasing an additional 1,398,774 shares during the last quarter. Finally, State Street Corp grew its position in Humana by 1.8% during the 4th quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock worth $1,403,877,000 after purchasing an additional 97,211 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Cantor Fitzgerald raised their price target on shares of Humana from $264.00 to $300.00 and gave the stock a “neutral” rating in a report on Tuesday, July 7th. William Blair started coverage on shares of Humana in a report on Wednesday, May 20th. They set an “outperform” rating on the stock. Robert W. Baird set a $390.00 target price on Humana in a research report on Thursday, July 30th. Bank of America upgraded Humana from a “neutral” rating to a “buy” rating and set a $500.00 target price for the company in a research note on Wednesday, July 29th. Finally, Raymond James Financial cut Humana from an “outperform” rating to a “market perform” rating in a research report on Thursday, July 30th. Fourteen research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Humana has a consensus rating of “Hold” and an average price target of $395.22.

Humana Trading Down 1.3%

Shares of Humana stock opened at $377.18 on Thursday. The firm has a 50-day simple moving average of $383.16 and a two-hundred day simple moving average of $279.59. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $428.88. The company has a market cap of $45.29 billion, a P/E ratio of 35.68, a price-to-earnings-growth ratio of 2.18 and a beta of 0.72.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The firm had revenue of $40.89 billion for the quarter, compared to analysts’ expectations of $40.58 billion. During the same period last year, the firm earned $6.27 EPS. The company’s quarterly revenue was up 26.2% on a year-over-year basis. As a group, equities analysts predict that Humana Inc. will post 9.08 earnings per share for the current fiscal year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.